Apimeds Pharmaceuticals US, Inc. (APUS) insider trading

Over the last 12 months, 0 insiders bought $0 and 0 insiders sold $0 of Apimeds Pharmaceuticals US, Inc. stock on the open market, according to SEC Form 4 filings.

Latest insider buys and sells

• May 14, 2025: Kim Christopher bought 27,500 shares ($50.4K)
• May 12, 2025: Koo Jakap bought 28,500 shares ($56.7K)